OralogiK has been validated in numerous clinical studies and allows for night time dosing, multi-phased delivery of drugs, and delivery to specific regions of the digestive system. BDD also specializes in gamma scintigraphy and provides a full clinical package, including protocol development and regulatory authority submission, to accelerate product development pipelines and create new value-added products.